Design and Synthesis of Potent, Selective Inhibitors of Endothelin-Converting Enzyme
- 1 April 1998
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 41 (9), 1513-1523
- https://doi.org/10.1021/jm970787c
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Potent non-peptidic dual inhibitors of endothelin-converting enzyme and neutral endopeptidase 24.11Bioorganic & Medicinal Chemistry Letters, 1997
- Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEXThe FASEB Journal, 1997
- The renoprotective potential of endothelin receptor antagonistsExpert Opinion on Therapeutic Patents, 1997
- Therapeutic Potential of Endothelin Receptor Antagonists in Cerebrovascular DiseaseCNS Drugs, 1996
- Molecular pharmacology of endothelin converting enzymesBiochemical Pharmacology, 1996
- Molecular characterization of human and bovine endothelin converting enzyme (ECE‐1)FEBS Letters, 1994
- Mechanisms of atrial natriuretic factor-induced vasodilationPharmacology & Therapeutics, 1990
- Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan.Proceedings of the National Academy of Sciences, 1989
- UK-69, 578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diureticBiochemical and Biophysical Research Communications, 1989
- The hydrolysis of α-human atrial natriuretic peptide by pig kidney microvillar membranes is initiated by endopeptidase-24.11Biochemical Journal, 1987